Autologous Co-culture Models to Humanized Mouse Models: Navigating IO Models

Logo
Presented by

Mara Gilardi, PhD, Subject Matter Expert: Immuno-Oncology, Champions Oncology, Inc.

About this talk

With an estimated 90% of oncology drugs failing clinical trials, there is a critical need for a more robust approach to preclinical and translational studies in immuno-oncology research. Advanced approaches to immuno-oncology research are being galvanized with new humanized mouse models and 3D co-culture techniques to better understand therapeutic intervention. However, understanding the best model is critical to building successful IO studies with interpretable readouts. In this webinar, we will provide insights into immuno-oncology ex vivo assays and in vivo models to help improve the accuracy of preclinical studies.
Related topics:

More from this channel

Upcoming talks (9)
On-demand talks (56)
Subscribers (3309)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.